Key Market Insights
- At present, more than 75 companies across the globe claim to offer manufacturing execution system in healthcare sector.
- Several manufacturing execution system providers have the necessary expertise to offer MES in different types of deployment (cloud, corporate datacenter hybrid and on premise); such players cater to the needs of a number of end users
- Most of the players offering manufacturing execution system to different end users are headquartered in Europe; Germany, UK, France and Switzerland have emerged as the most prominent countries within this region
- The growing interest is also evident from the rise in partnership activity; a major proportion of the deals were signed by companies based in Europe
- Built on our proprietary scoring criteria, we have proposed a company competitive analysis on several relevant parameters, such as, product portfolio strength and partnership strength
- The projected manufacturing execution system market opportunity is likely to be distributed across different type of deployments, type of end-users and key geographical regions
Table of Contents
- Background
1.1 Context
1.2 Project Approach
- EXECUTIVE SUMMARY
- INTRODUCTION
3.1. Overview of Manufacturing Execution Systems
3.2. Core Function of Manufacturing Execution Systems
3.3 Deployment Models of Manufacturing Execution Systems
3.4 Benefits Offered by Manufacturing Execution Systems
3.5 Challenges Associated with Manufacturing Execution Systems
3.6 Integration of Manufacturing Execution Systems for Different Operations
3.7 Concluding Remarks
- MARKET LANDSCAPE
4.1. Manufacturing Execution System Providers in Healthcare: Market Overview
4.2. List of Manufacturing Execution System Providers in Healthcare
4.3. Analysis by Year of Establishment
4.4. Analysis by Company Size
4.5. Analysis by Location of Headquarters
4.6. Analysis by Type of Deployment
4.7. Analysis by Integrating Software
4.8. Analysis by Type of License
4.9. Analysis by Type of End User
4.10. Analysis by Key Features
4.11. Analysis by Type of Service(s) Offered
4.12. Analysis by Quality Certifications Received
- KEY INSIGHTS
5.1. Analysis by Year of Establishment and Region of Headquarters
5.2. Analysis by Company Size and Type of Deployment
5.3. Analysis by Type of License and End User
5.4. Analysis by Company Size and Key Features
5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)
- PARTNERSHIPS AND COLLABORATIONS
6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
6.2. Analysis by Year of Partnership
6.3. Analysis by Type of Partnership
6.4. Analysis by Year of Partnership and Type of Partnership
6.5. Analysis by Type of Partnership and Company Size
6.6. Key Players: Analysis by Number of Partnerships
6.7. Analysis by Type of Partner
6.8. Analysis by Country
6.9. Analysis by Region
6.10. Intercontinental and Intracontinental Deals
6.11. Analysis by Location of Headquarters of Partner
6.12. Analysis by Type of Partnership and Location of Headquarters of Partner
- COMPANY COMPETITIVENESS ANALYSIS
7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Partnership Activity
7.6. Company Competitiveness Analysis: Very Large Players
7.7. Company Competitiveness Analysis: Large Players
7.8. Company Competitiveness Analysis: Mid-Sized Players
7.9. Company Competitiveness Analysis: Small Players
- COMPANY PROFILES
8.1. Andea
8.1.1. Company Overview
8.1.2. Technology Portfolio
8.1.3. Recent Developments and Future Outlook
8.2. Critical Manufacturing
8.3. Dassault Systèmes
8.4. GE Digital
8.5. Infor
8.6. Körber
8.7. Rockwell Automation
- VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS
9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
9.2. Key Assumptions and Methodology
9.3. Key Tools and Technologies
9.4. Extent of Innovation versus Associated Risks
9.5 Concluding Remarks
- MARKET FORECAST
10.1. Key Assumptions and Forecast Methodology
10.2. Forecasted Market Segments
10.3. Manufacturing Execution System Providers in Healthcare Market, 2022-2035
10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, 2022-2035
10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, 2022-2035
10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, 2022-2035
- EXECUTIVE INSIGHTS
11.1. NoMuda
11.1.1. Company Snapshot
11.1.2. Interview Transcript: Philip Borland (Chief Executive Officer)
11.2. ORDINAL Software
11.3. Trunovate
- APPENDICES I: OTHER FIGURES
12.1. Market Overview
12.2. Key Insights
12.3. Partnerships and Collaborations
12.4. List of Figures
- APPENDICES II: TABULATED DATA
- APPENDICES III: LIST OF COMPANIES
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
